Fannin Innovation Studio Names Melissa Singh Principal

Life science commercialization company Fannin Innovation Studio ( today promoted its first entrepreneur fellow, biomedical scientist Melissa Singh, Ph.D., to principal. With this move, entrepreneur fellow Erol Bakkalbasi, M.Sc. has been named senior entrepreneur... - February 17, 2016

Fannin Innovation Studio Forms Molecular Therapeutics Company Exotect, LLC.

Researchers behind Exotect LLC have honed in on a novel molecular pathway that controls the overproduction of mucus during asthma attacks. More than 25 million people suffer with asthma, a chronic disease in which airways become inflamed, swell and produce excess mucus making it difficult to breathe. - November 07, 2015

Fannin Innovation Studio’s Atul Varadhachary Appointed to Jones Health Care Advisory Board

Diverse group of industry leaders to enhance Rice University’s Health Care Initiative. - October 24, 2015

Fannin Innovation Studio Expands Team as Life Science Portfolio Grows

Dr. Michael Heffernan to lead R&D of novel biomedical technologies. - July 29, 2015

Fannin Innovation Studio and University of Houston Announce the Formation of GuidaBot, LLC

Technology enables interventions using real-time MRI guidance. - July 25, 2015

Houston Biotech Firm Closes $7.3 Million Fundraising Round

Early-stage life science commercialization company Fannin Partners, LLC announced the completion of its private offering of Class A units. Proceeds from the offering will fund the further expansion of the company’s portfolio of startups. - March 06, 2015

Press Releases 1 - 6 of 6